Literature DB >> 27136668

Adherence to antidepressants is associated with lower mortality: a 4-year population-based cohort study.

Amir Krivoy1, Ran D Balicer, Becca Feldman, Moshe Hoshen, Gil Zalsman, Abraham Weizman, Gal Shoval.   

Abstract

OBJECTIVE: Despite the growing use of antidepressants and the potential grave consequences of inadequate treatment, little is known about the impact of adherence to antidepressant treatment on mortality in the general population. The objective of this study was to evaluate the association between adherence to antidepressants and all-cause mortality in a population-based cohort.
METHODS: Data were extracted from the electronic medical record database of the largest health provider in Israel (53% of the nation's population) on a total of 251,745 patients aged 40 years and above who filled an antidepressant prescription at least once between 2008 and 2011. The main outcome measure was all-cause mortality during the study period. Adherence was measured as a continuous variable representing possession ratio (duration of filled antidepressant divided by duration of prescribed antidepressant). A polynomial model of proportional hazard Cox regression for multivariable survival analysis was used, adjusting for demographic and clinical variables that affect mortality.
RESULTS: The association between adherence and the hazard ratio (HR) for mortality follows a quadratic model in which the lowest HR (0.66 [95% CI, 0.64-0.69]) is at a level of 60% adherence in respect to nonadherence.
CONCLUSIONS: Adherence to antidepressants is significantly associated with a corresponding decrease in the risk of mortality, controlling for relevant covariates. Physicians from all disciplines should actively improve their patients' adherence to antidepressants since their persistent use is associated with increased survival. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27136668     DOI: 10.4088/JCP.14m09531

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial.

Authors:  Jo Anne Sirey; Samprit Banerjee; Patricia Marino; Martha L Bruce; Ashley Halkett; Molly Turnwald; Claire Chiang; Brian Liles; Amanda Artis; Fred Blow; Helen C Kales
Journal:  JAMA Psychiatry       Date:  2017-11-01       Impact factor: 21.596

2.  Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).

Authors:  Katelyn R Keyloun; Ryan N Hansen; Zsolt Hepp; Patrick Gillard; Michael E Thase; Emily Beth Devine
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

3.  All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.

Authors:  I J A de Bruin; C Klop; C E Wyers; J A Overbeek; P P M M Geusens; J P W van den Bergh; J H M Driessen; F de Vries
Journal:  Osteoporos Int       Date:  2019-02-08       Impact factor: 4.507

Review 4.  Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.

Authors:  Danielle Hen-Shoval; Aron Weller; Abraham Weizman; Gal Shoval
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

5.  Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence".

Authors:  Mario Gennaro Mazza; Benedetta Vai; Livia De Picker; Francesco Benedetti; Raffaella Zanardi
Journal:  Drugs       Date:  2022-02-12       Impact factor: 11.431

6.  Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.

Authors:  Shiau-Shian Huang; Hsi-Han Chen; Jui Wang; Wei J Chen; Hsi-Chung Chen; Po-Hsiu Kuo
Journal:  BMC Psychiatry       Date:  2020-11-17       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.